KR102797285B1 - 대두 알레르기의 항원 - Google Patents

대두 알레르기의 항원 Download PDF

Info

Publication number
KR102797285B1
KR102797285B1 KR1020247024646A KR20247024646A KR102797285B1 KR 102797285 B1 KR102797285 B1 KR 102797285B1 KR 1020247024646 A KR1020247024646 A KR 1020247024646A KR 20247024646 A KR20247024646 A KR 20247024646A KR 102797285 B1 KR102797285 B1 KR 102797285B1
Authority
KR
South Korea
Prior art keywords
protein
amino acid
seq
acid sequence
base sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020247024646A
Other languages
English (en)
Korean (ko)
Other versions
KR20240116585A (ko
Inventor
카요코 마츠나가
아키코 야가미
나오시 시모죠
마사시 나카무라
나유 사토
Original Assignee
호유 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호유 가부시키가이샤 filed Critical 호유 가부시키가이샤
Priority claimed from PCT/JP2017/008593 external-priority patent/WO2017150724A1/ja
Publication of KR20240116585A publication Critical patent/KR20240116585A/ko
Application granted granted Critical
Publication of KR102797285B1 publication Critical patent/KR102797285B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/30—Removing undesirable substances, e.g. bitter substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/10—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
KR1020247024646A 2016-03-03 2017-03-03 대두 알레르기의 항원 Active KR102797285B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016041547 2016-03-03
JPJP-P-2016-041547 2016-03-03
PCT/JP2017/008593 WO2017150724A1 (ja) 2016-03-03 2017-03-03 大豆アレルギーの抗原
KR1020227041429A KR102688761B1 (ko) 2016-03-03 2017-03-03 대두 알레르기의 항원

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020227041429A Division KR102688761B1 (ko) 2016-03-03 2017-03-03 대두 알레르기의 항원

Publications (2)

Publication Number Publication Date
KR20240116585A KR20240116585A (ko) 2024-07-29
KR102797285B1 true KR102797285B1 (ko) 2025-04-18

Family

ID=81214383

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020247024646A Active KR102797285B1 (ko) 2016-03-03 2017-03-03 대두 알레르기의 항원
KR1020227041429A Active KR102688761B1 (ko) 2016-03-03 2017-03-03 대두 알레르기의 항원

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020227041429A Active KR102688761B1 (ko) 2016-03-03 2017-03-03 대두 알레르기의 항원

Country Status (4)

Country Link
US (1) US12440558B2 (https=)
JP (8) JP7041923B2 (https=)
KR (2) KR102797285B1 (https=)
CN (1) CN115248317A (https=)

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
JP2654889B2 (ja) 1991-06-05 1997-09-17 株式会社ホーネンコーポレーション 幼令動物飼料用原料
US6555116B1 (en) * 1991-10-12 2003-04-29 Regents Of The University Of California Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
US5792506A (en) * 1991-10-12 1998-08-11 The Regents Of The University Of California Neutralization of food allergens by thioredoxin
JP3399668B2 (ja) * 1994-01-07 2003-04-21 不二製油株式会社 分画大豆蛋白の製造法及びこれを用いた食品
JPH0856600A (ja) * 1994-08-26 1996-03-05 Allergen Furii Technol Kenkyusho:Kk 大豆のアレルゲン低減化方法
JPH08308506A (ja) * 1995-05-11 1996-11-26 Allergen Furii Technol Kenkyusho:Kk 大豆蛋白食品素材の製造方法
JPH0923822A (ja) * 1995-07-14 1997-01-28 Nichimo Co Ltd ペプチド生成物およびその製造方法
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
JPH09136897A (ja) * 1995-11-15 1997-05-27 Hitachi Chem Co Ltd 大豆抗原組成物、その製造法、抗大豆抗体の検出・測定方法及び大豆アレルギー診断薬
JP3417461B2 (ja) * 1997-12-24 2003-06-16 不二製油株式会社 大豆蛋白分解物、その製造法及びその利用食品
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
US20030166518A1 (en) * 2000-01-13 2003-09-04 Beardslee Thomas A. Method for allergen characterization
JP2001211851A (ja) 2000-02-02 2001-08-07 Allergen Free Technology Kenkyusho:Kk アレルゲン低減化大豆蛋白食品の製造方法
US6864362B2 (en) * 2000-03-16 2005-03-08 E. I. Du Pont De Nemours And Company Hypoallergenic transgenic soybeans
JP4578709B2 (ja) 2001-03-28 2010-11-10 三菱化学メディエンス株式会社 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
ATE414534T1 (de) * 2001-12-05 2008-12-15 Circassia Ltd Immunotherapeutische methoden und systeme
JP2005185101A (ja) 2002-05-30 2005-07-14 National Institute Of Agrobiological Sciences 植物の全長ｃＤＮＡおよびその利用
WO2004069863A2 (en) 2003-02-04 2004-08-19 New York University Constrained hiv v3 loop peptides as immunogens and receptor antagonists
JP4001239B2 (ja) * 2004-01-23 2007-10-31 国立大学法人京都大学 ダイズ由来ペプチド混合物およびその利用
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
KR101413844B1 (ko) 2008-12-09 2014-06-30 화이자 백신스 엘엘씨 ＩｇＥ ＣＨ３ 펩티드 백신
JP5475358B2 (ja) 2009-08-04 2014-04-16 ホーユー株式会社 ２次元電気泳動方法
JP5190423B2 (ja) 2009-08-04 2013-04-24 ホーユー株式会社 ２次元電気泳動方法
JP5513802B2 (ja) 2009-08-04 2014-06-04 ホーユー株式会社 等電点電気泳動用ゲル及び等電点電気泳動方法
JP5433341B2 (ja) 2009-08-04 2014-03-05 ホーユー株式会社 等電点電気泳動方法及び粗雑物除去の判定方法
KR101046284B1 (ko) 2009-09-25 2011-07-04 한국건설기술연구원 자연환기식 유니트의 필터 교체구조
KR20110033546A (ko) 2009-09-25 2011-03-31 장동원 바스켓이 구비된 저수형 오수받이
KR101060752B1 (ko) 2009-09-25 2011-08-30 한국전력공사 나선형 파형관용 이음장치
KR101123843B1 (ko) 2009-09-25 2012-03-19 홍석희 가시설 구조체의 평형 상태 평가, 조정, 예측 방법 및 그 장치
WO2013040142A2 (en) 2011-09-16 2013-03-21 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
MX2014011459A (es) 2012-03-26 2015-02-04 Pronutria Inc Proteinas nutritivas cargadas y metodos.
EP3004141A4 (en) 2013-06-03 2017-05-31 Acetylon Pharmaceuticals, Inc. Histone deacetylase ( hdac) biomarkers in multiple myeloma
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
WO2015101435A1 (en) 2013-12-30 2015-07-09 Koninklijke Philips N.V. A method of making soymilk
CN106662578B (zh) 2014-04-03 2021-11-12 艾勒詹尼斯有限责任公司 用于检测食物变态反应的肽、试剂和方法
WO2015156106A1 (ja) * 2014-04-11 2015-10-15 株式会社カネカ 発酵食品組成物の製造方法
US9856315B2 (en) 2014-10-15 2018-01-02 Cell Signaling Technology, Inc. Methylation and acetylation sites
CA2988388C (en) 2015-04-23 2022-11-22 Nantomics, Llc Cancer neoepitopes
KR102330507B1 (ko) 2016-03-03 2021-11-23 호유 가부시키가이샤 대두 알레르기의 항원
JP7808537B2 (ja) * 2022-09-30 2026-01-29 株式会社神鋼環境ソリューション 清掃用リング

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Bradon et al, Journal of Agricultural and Food Chemistry (2002.10.23.), vol 50, no 22, pp 6635-6642.
Friedman M et al, Journal of Agricultural and Food Chemistry (2001.02.17.), vol 49, no 3, pp 1069-1086.
Jiao J et al, Journal of Agricultural and Food Chemistry (1992), vol 40, pp 2333-2336.
John Jaime Riascos et al, North Carolina State University ProQuest Dissertations Publishing (2009), pp 1-209.
Oh Woo Yeon et al, 대한약학회, 춘계총회 및 학술대회 (2015.04.), pp 429.
Rakhi Panda et al, Bradon et al, Soybean Allergy: Effect of Genetic Modification, Heat and Enzymatic Treatment on Overall Allergenicity (2012.12.), University of Nebraska, pp 1-219.

Also Published As

Publication number Publication date
KR20240116585A (ko) 2024-07-29
JP2024079829A (ja) 2024-06-11
JP2022075738A (ja) 2022-05-18
CN115248317A (zh) 2022-10-28
JPWO2017150724A1 (ja) 2019-02-21
US12440558B2 (en) 2025-10-14
JP2025026540A (ja) 2025-02-21
JP2026050466A (ja) 2026-03-19
JP2022115966A (ja) 2022-08-09
JP2026062970A (ja) 2026-04-10
JP2023182642A (ja) 2023-12-26
KR20220165796A (ko) 2022-12-15
JP7041923B2 (ja) 2022-03-25
JP7807759B2 (ja) 2026-01-28
US20240123063A1 (en) 2024-04-18
KR102688761B1 (ko) 2024-07-29

Similar Documents

Publication Publication Date Title
JP7727288B2 (ja) アレルギーの抗原およびそのエピトープ
KR102472388B1 (ko) 대두 알레르기의 항원
CN109313181B (zh) 蛋变态反应的抗原
KR102102031B1 (ko) 메추리알 알레르기의 항원
KR102797285B1 (ko) 대두 알레르기의 항원
KR20210095986A (ko) 알레르기 항원 및 그 에피토프

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20240722

Application number text: 1020227041429

Filing date: 20221125

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240819

Comment text: Request for Examination of Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20241209

PX0701 Decision of registration after re-examination

Patent event date: 20250131

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250414

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250415

End annual number: 3

Start annual number: 1

PG1601 Publication of registration